Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™

P Frederiks, G Castaldi, K McCutcheon… - Expert Review of …, 2024 - Taylor & Francis
Introduction The introduction of drug-eluting coronary stents (DES) into clinical practice in
2002 represented a major milestone in the treatment of obstructive coronary artery disease …
相关文章

Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™

P Frederiks, G Castaldi, K McCutcheon… - Expert Review Of …, 2024 - lirias.kuleuven.be
INTRODUCTION: The introduction of drug-eluting coronary stents (DES) into clinical practice
in 2002 represented a major milestone in the treatment of obstructive coronary artery …

Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™

P Frederiks, G Castaldi, K McCutcheon… - Expert review of … - pubmed.ncbi.nlm.nih.gov
Introduction The introduction of drug-eluting coronary stents (DES) into clinical practice in
2002 represented a major milestone in the treatment of obstructive coronary artery disease …

Platinum chromium everolimus-eluting stents for the treatment of (complex) coronary artery disease; from SYNERGY™ to the MEGATRON™.

P Frederiks, G Castaldi, K McCutcheon… - Expert Review of …, 2024 - europepmc.org
The introduction of drug-eluting coronary stents (DES) into clinical practice in 2002
represented a major milestone in the treatment of obstructive coronary artery disease. Over …